Skip to content
Siedlerstraße 7 | 68623 Lampertheim, Germany
info@zamann-pharma.com
Request an appointment now
EN
DE
Home
Consultancy Services
Client Cases
Newsroom
About us
Portfolio
Contact
Home
Consultancy Services
Client Cases
Newsroom
About us
Portfolio
Contact
2
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
Z
Glossary
Annex 15 EUGMP
Annex I (MDR/IVDR)
Annex II (MDR/IVDR)
Annex III (MDR/IVDR)
Antigen Test
Antioxidants
Antiviral Drugs
Antiviral Drugs (Virostatics)
API Manufacturing
API Purification
Page
1
…
Page
4
Page
5
Page
6
Page
7
Page
8
…
Page
108
Continuous Improvement in QMS
Continuous Improvement Process (CIP)
Continuous Integration (CI)
Continuous Monitoring
Continuous Monitoring
Continuous Risk Assessment
Continuous Validation
Control Strategies
Convolutional Neural Network (CNN)
Corporate Sustainability
Corrective Action
Corrective Action Plan
Corrective Action Plan (CAP)
Corrective Actions
Corrective and Preventive Action (CAPA)
Corrective and Preventive Action (CAPA)
Corrective and Preventive Actions (CAPA)
Corrective and Preventive Actions (CAPA)
Cost-Effectiveness of Cloud QMS
Counterfeit Drug Prevention
Counterfeit Medical Components
COVID-19 Vaccine Monitoring
CPCA Category
Crisis Management Planning
Critical Gap
Critical Thinking
Critical Thinking in CSV
Cross-Contamination Prevention
Cross-Departmental Communication
Cross-Functional Teams
Crossroads of Technology and Life Sciences
CSV Test Automation
Customer Complaint Form
Customer Satisfaction
Customer-Centric Approach
Customer-Related Quality
Customer-Specific Quality Management Systems
Customer-Specific Quality Solutions
Customization in QMS
Cybersecurity in Medical Devices
Page
1
…
Page
4
Page
5
Page
6
Page
7
Page
8
…
Page
27